Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
Clinical trial NCT04983121 · RECRUITING
Trial details
- NCT number
- NCT04983121
- Sponsor
- Shengjing Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2027-08-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.